| Deoxycholic acid | Approved Investigational | NR0B2 | 8431 |
upregulated | Deoxycholic Acid results in increased expression of NR0B2 mRNA | 1p36.11 | |
| Deoxycholic acid | Approved Investigational | NR1H4 | 9971 |
upregulated | Deoxycholic Acid results in increased expression of NR1H4 mRNA | 12q23.1 | |
| Deoxycholic acid | Approved Investigational | PTGS2 | 5743 |
upregulated | Deoxycholic Acid results in increased expression of PTGS2 mRNA | 1q31.1 | |
| Deoxycholic acid | Approved Investigational | PTGS2 | 5743 |
upregulated | [SLCO1B3 protein results in increased transport of Deoxycholic Acid] which results in increased expression of PTGS2 mRNA | 1q31.1 | |
| Deoxycholic acid | Approved Investigational | SCARB1 | 949 |
upregulated | Deoxycholic Acid results in increased expression of SCARB1 mRNA | 12q24.31 | |
| Deoxycholic acid | Approved Investigational | SELE | 6401 |
upregulated | Deoxycholic Acid results in increased expression of SELE mRNA | 1q24.2 | |
| Deoxycholic acid | Approved Investigational | SLC51A | 200931 |
upregulated | Deoxycholic Acid results in increased expression of SLC51A mRNA | 3q29 | |
| Deoxycholic acid | Approved Investigational | SLC51B | 123264 |
upregulated | Deoxycholic Acid results in increased expression of SLC51B mRNA | 15q22.31 | |
| Deoxycholic acid | Approved Investigational | SLCO1B3 | 28234 |
upregulated | Deoxycholic Acid results in increased expression of SLCO1B3 mRNA | 12p12.2 | |
| Deoxycholic acid | Approved Investigational | TNF | 7124 |
downregulated | Deoxycholic Acid results in decreased expression of TNF mRNA | 6p21.33 | |
| Deoxycholic acid | Approved Investigational | VCAM1 | 7412 |
upregulated | Deoxycholic Acid results in increased expression of VCAM1 mRNA | 1p21.2 | |
| Dexamethasone | Approved Investigational Vet Approved | A2M | 2 |
upregulated | Dexamethasone results in increased expression of A2M mRNA | 12p13.31 | |
| Dexamethasone | Approved Investigational Vet Approved | AAED1 | 195827 |
upregulated | Dexamethasone results in increased expression of AAED1 mRNA | 9q22.33 | |
| Dexamethasone | Approved Investigational Vet Approved | ABAT | 18 |
upregulated | Dexamethasone results in increased expression of ABAT mRNA | 16p13.2 | |
| Dexamethasone | Approved Investigational Vet Approved | ABCA6 | 23460 |
upregulated | Dexamethasone results in increased expression of ABCA6 mRNA | 17q24.2-q24.3 | |
| Dexamethasone | Approved Investigational Vet Approved | ABCB1 | 5243 |
upregulated | Dexamethasone results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Dexamethasone | Approved Investigational Vet Approved | ABCB11 | 8647 |
upregulated | Dexamethasone results in increased expression of ABCB11 mRNA | 2q31.1 | |
| Dexamethasone | Approved Investigational Vet Approved | ABCC2 | 1244 |
upregulated | Dexamethasone results in increased expression of ABCC2 mRNA | 10q24.2 | |
| Dexamethasone | Approved Investigational Vet Approved | ABCC3 | 8714 |
upregulated | Dexamethasone results in increased expression of ABCC3 mRNA | 17q21.33 | |
| Dexamethasone | Approved Investigational Vet Approved | ABCD2 | 225 |
upregulated | Dexamethasone results in increased expression of ABCD2 mRNA | 12q12 | |
| Dexamethasone | Approved Investigational Vet Approved | ABHD14A | 25864 |
upregulated | Dexamethasone results in increased expression of ABHD14A mRNA | 3p21.2 | |
| Dexamethasone | Approved Investigational Vet Approved | ABHD5 | 51099 |
upregulated | Dexamethasone results in increased expression of ABHD5 mRNA | 3p21.33 | |
| Dexamethasone | Approved Investigational Vet Approved | ACACB | 32 |
upregulated | Dexamethasone results in increased expression of ACACB mRNA | 12q24.11 | |
| Dexamethasone | Approved Investigational Vet Approved | ACAN | 176 |
downregulated | Dexamethasone results in decreased expression of ACAN mRNA | 15q26.1 | |
| Dexamethasone | Approved Investigational Vet Approved | ACAN | 176 |
upregulated | Dexamethasone results in increased expression of ACAN mRNA | 15q26.1 | |